Return On Equity of Armata Pharmaceuticals, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Armata Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Armata Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 70%, a 21% decline year-over-year.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2024 was 38%, a 100% decline from 2023.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2023 was 9653%.
  • Armata Pharmaceuticals, Inc. annual Return On Equity for 2022 was -75%, a 9.3% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Armata Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 70% -19% -21% 01 Jul 2025 30 Sep 2025
Q2 2025 46% -136% -75% 01 Apr 2025 30 Jun 2025
Q1 2025 0.86% -388% -100% 01 Jan 2025 31 Mar 2025
Q4 2024 38% -9616% -100% 01 Oct 2024 31 Dec 2024
Q3 2024 89% +454% 01 Jul 2024 30 Sep 2024
Q2 2024 182% +302% 01 Apr 2024 30 Jun 2024
Q1 2024 389% +497% 01 Jan 2024 31 Mar 2024
Q4 2023 9653% +9728% 01 Oct 2023 31 Dec 2023
Q3 2023 -365% -294% -419% 01 Jul 2023 30 Sep 2023
Q2 2023 -120% -48% -67% 01 Apr 2023 30 Jun 2023
Q1 2023 -108% -32% -43% 01 Jan 2023 31 Mar 2023
Q4 2022 -75% +7.7% +9.3% 01 Oct 2022 31 Dec 2022
Q3 2022 -70% +20% +22% 01 Jul 2022 30 Sep 2022
Q2 2022 -72% +19% +21% 01 Apr 2022 30 Jun 2022
Q1 2022 -76% +8.5% +10% 01 Jan 2022 31 Mar 2022
Q4 2021 -83% +0.38% +0.46% 01 Oct 2021 31 Dec 2021
Q3 2021 -90% -11% -15% 01 Jul 2021 30 Sep 2021
Q2 2021 -91% -1.8% -2% 01 Apr 2021 30 Jun 2021
Q1 2021 -84% +9.4% +10% 01 Jan 2021 31 Mar 2021
Q4 2020 -83% +48% +37% 01 Oct 2020 31 Dec 2020
Q3 2020 -79% +93% +54% 01 Jul 2020 30 Sep 2020
Q2 2020 -89% +81% +48% 01 Apr 2020 30 Jun 2020
Q1 2020 -94% +123% +57% 01 Jan 2020 31 Mar 2020
Q4 2019 -131% +25% +16% 01 Oct 2019 31 Dec 2019
Q3 2019 -172% -95% -123% 01 Jul 2019 30 Sep 2019
Q2 2019 -170% -108% -172% 01 Apr 2019 30 Jun 2019
Q1 2019 -216% -130% -149% 01 Jan 2019 31 Mar 2019
Q4 2018 -156% -55% -54% 01 Oct 2018 31 Dec 2018
Q3 2018 -77% +145% +65% 01 Jul 2018 30 Sep 2018
Q2 2018 -62% +132% +68% 01 Apr 2018 30 Jun 2018
Q1 2018 -87% +49% +36% 01 Jan 2018 31 Mar 2018
Q4 2017 -101% +28% +21% 01 Oct 2017 31 Dec 2017
Q3 2017 -222% -147% -194% 01 Jul 2017 30 Sep 2017
Q2 2017 -194% -169% -660% 01 Apr 2017 30 Jun 2017
Q1 2017 -135% -222% -257% 01 Jan 2017 31 Mar 2017
Q4 2016 -129% -124% -2303% 01 Oct 2016 31 Dec 2016
Q3 2016 -75% -90% -623% 01 Jul 2016 30 Sep 2016
Q2 2016 -26% -403% -107% 01 Apr 2016 30 Jun 2016
Q1 2016 86% +690% 01 Jan 2016 31 Mar 2016
Q4 2015 -5.4% +204% +97% 01 Oct 2015 31 Dec 2015
Q3 2015 14% +153% 01 Jul 2015 30 Sep 2015
Q2 2015 378% 01 Apr 2015 30 Jun 2015
Q1 2015 -604% 01 Jan 2015 31 Mar 2015
Q4 2014 -209% 01 Oct 2014 31 Dec 2014
Q3 2014 -138% 01 Jul 2014 30 Sep 2014

Armata Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 38% -9616% -100% 01 Jan 2024 31 Dec 2024
2023 9653% +9728% 01 Jan 2023 31 Dec 2023
2022 -75% +7.7% +9.3% 01 Jan 2022 31 Dec 2022
2021 -83% +0.38% +0.46% 01 Jan 2021 31 Dec 2021
2020 -83% +48% +37% 01 Jan 2020 31 Dec 2020
2019 -131% +25% +16% 01 Jan 2019 31 Dec 2019
2018 -156% -55% -54% 01 Jan 2018 31 Dec 2018
2017 -101% +28% +21% 01 Jan 2017 31 Dec 2017
2016 -129% -124% -2303% 01 Jan 2016 31 Dec 2016
2015 -5.4% +204% +97% 01 Jan 2015 31 Dec 2015
2014 -209% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.